TVTX |
Travere Therapeutics, Inc. |
Sep 5, 2024 |
2 |
-$243K |
4 |
Sep 9, 2024 |
CHIEF EXECUTIVE OFFICER, Director |
TVTX |
Travere Therapeutics, Inc. |
Jan 31, 2024 |
4 |
-$166K |
4 |
Feb 2, 2024 |
CHIEF EXECUTIVE OFFICER, Director |
TVTX |
Travere Therapeutics, Inc. |
Jan 23, 2024 |
1 |
-$70.5K |
4 |
Jan 25, 2024 |
CHIEF EXECUTIVE OFFICER, Director |
TVTX |
Travere Therapeutics, Inc. |
Aug 31, 2023 |
2 |
-$65.5K |
4 |
Sep 5, 2023 |
Chief Executive Officer, Director |
RPHM |
Reneo Pharmaceuticals, Inc. |
Jun 6, 2023 |
1 |
$0 |
4 |
Jun 8, 2023 |
Director |
TVTX |
Travere Therapeutics, Inc. |
Jan 31, 2023 |
4 |
-$182K |
4 |
Feb 2, 2023 |
Chief Executive Officer, Director |
TVTX |
Travere Therapeutics, Inc. |
Jan 24, 2023 |
1 |
-$139K |
4 |
Jan 26, 2023 |
Chief Executive Officer, Director |
TVTX |
Travere Therapeutics, Inc. |
Jan 5, 2023 |
1 |
-$117K |
4 |
Jan 6, 2023 |
Chief Executive Officer, Director |
RPHM |
Reneo Pharmaceuticals, Inc. |
Jun 1, 2022 |
1 |
$0 |
4 |
Jun 3, 2022 |
Director |
TVTX |
Travere Therapeutics, Inc. |
Feb 10, 2022 |
1 |
-$135K |
4 |
Feb 11, 2022 |
Chief Executive Officer, Director |
TVTX |
Travere Therapeutics, Inc. |
Jan 31, 2022 |
4 |
-$132K |
4 |
Feb 2, 2022 |
Chief Executive Officer, Director |
TVTX |
Travere Therapeutics, Inc. |
Jan 24, 2022 |
1 |
-$197K |
4 |
Jan 26, 2022 |
Chief Executive Officer, Director |
TVTX |
Travere Therapeutics, Inc. |
Jan 4, 2022 |
3 |
-$521K |
4 |
Jan 6, 2022 |
Chief Executive Officer, Director |
TVTX |
Travere Therapeutics, Inc. |
Aug 13, 2021 |
2 |
-$134K |
4 |
Aug 17, 2021 |
Chief Executive Officer, Director |
TVTX |
Travere Therapeutics, Inc. |
Jun 1, 2021 |
2 |
-$140K |
4 |
Jun 3, 2021 |
Chief Executive Officer, Director |